Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 507, 98-103
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 19 references indexed in Scilit:
- Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassaysJournal Of Hypertension, 2015
- Laboratory challenges in primary aldosteronism screening and diagnosisClinical Biochemistry, 2015
- An LC–MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronismThe Journal of Steroid Biochemistry and Molecular Biology, 2015
- Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC–MS/MS and comparison with commercial immunoassaysJournal of Chromatography B, 2014
- Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometryJournal of Chromatography B, 2013
- Observational Study Mortality in Treated Primary AldosteronismHypertension, 2012
- Pitfalls Associated with the Use of Liquid Chromatography–Tandem Mass Spectrometry in the Clinical LaboratoryClinical Chemistry, 2010
- Determination of aldosterone in serum by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2008
- Automated Chemiluminescence-Immunoassay for Aldosterone during Dynamic Testing: Comparison to Radioimmunoassays with and without Extraction StepsClinical Chemistry, 2006
- The production of monoclonal antibodies against aldosteroneSteroids, 1987